Mengwei Tian, Xia Zhang, Na Wang, Zhanjun Dou, Xia Song. "A real-world study on first-line (1L) treatment for 46 advanced lung adenocarcinoma patients harbouring epidermal growth factor 20 insertion mutation (EGFR ex20ins).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.e20652